MKI67 and central nervous system cancer: tested 93 histologically confirmed WHO grade II glioma tissues by using immunohistochemical staining and concluded that Ki‐67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control; thus, Ki‐67 is a potential molecular marker to predict poor seizure control after surgery.120